4'-Methyl-α-pyrrolidinopropiophenone
Wikipedia on Answers.com:
Top
4'-Methyl-α-pyrrolidinopropiophenone
For other uses, see MPPP (disambiguation).
 |
|
|---|---|
| Systematic (IUPAC) name | |
| (RS)-1-(4-methylphenyl)-2-(1-pyrrolidinyl)-1-propanone | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Unscheduled |
| Identifiers | |
| CAS number | 1313393-58-6 28117-80-8 |
| ATC code | ? |
| PubChem | CID 6430745 |
| Chemical data | |
| Formula | C14H19NO |
| Mol. mass | 217.306 g/mol |
| SMILES | eMolecules & PubChem |
4'-Methyl-α-pyrrolidinopropiophenone (4-MePPP, MPPP or MαPPP) is a stimulant drug. It is structurally very similar to α-PPP, with only one added methyl group in the para position on the phenyl ring. 4-MePPP was sold in Germany as a designer drug in the late 1990s and early 2000s,[1][2][3] along with a number of other pyrrolidinophenone derivatives.[4][5] Although it has never achieved the same international popularity as its better-known relations α-PPP and MDPV, 4-MePPP is still sometimes found as an ingredient of grey-market "bath salt" blends[6] such as "NRG-3".[6]
The name MPPP can be misleading and should not be used, since another drug, an opioid with the acronym MPPP (desmethylprodine), already exists.
See also
- α-Pyrrolidinopropiophenone (α-PPP)
- 4'-Methoxy-α-pyrrolidinopropiophenone (MOPPP)
- 3,4-Methylenedioxy-α-pyrrolidinopropiophenone (MDPPP)
- 3',4'-Methylenedioxy-α-pyrrolidinobutiophenone (MDPBP)
References
- ^ Springer, D; Peters, FT; Fritschi, G; Maurer, HH (2002). "Studies on the metabolism and toxicological detection of the new designer drug 4'-methyl-alpha-pyrrolidinopropiophenone in urine using gas chromatography-mass spectrometry". Journal of Chromatography B 773 (1): 25–33. doi:10.1016/S1570-0232(01)00578-5. PMID 12015267.
- ^ Springer, D; Paul, LD; Staack, RF; Kraemer, T; Maurer, HH (2003). "Identification of cytochrome p450 enzymes involved in the metabolism of 4'-methyl-alpha-pyrrolidinopropiophenone, a novel scheduled designer drug, in human liver microsomes". Drug metabolism and disposition: the biological fate of chemicals 31 (8): 979–82. doi:10.1124/dmd.31.8.979. PMID 12867484.
- ^ Springer, D; Fritschi, G; Maurer, HH (2003). "Metabolism of the new designer drug alpha-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4'-methyl-alpha-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry". Journal of Chromatography B 796 (2): 253–66. doi:10.1016/j.jchromb.2003.07.008. PMID 14581066.
- ^ Maurer, HH; Kraemer, T; Springer, D; Staack, RF (2004). "Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis". Therapeutic drug monitoring 26 (2): 127–31. doi:10.1097/00007691-200404000-00007. PMID 15228152.
- ^ Staack, RF; Maurer, HH (2005). "Metabolism of designer drugs of abuse". Current drug metabolism 6 (3): 259–74. doi:10.2174/1389200054021825. PMID 15975043.
- ^ a b Brandt SD, Freeman S, Sumnall HR, Measham F, Cole J (December 2010). "Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones". Drug Testing and Analysis 3 (9): 569–75. doi:10.1002/dta.204. PMID 21960541.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
Post a question - any question - to the WikiAnswers community:
Copyrights:
Wikipedia on Answers.com
This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article 4'-Methyl-α-pyrrolidinopropiophenone.
Read more